Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
复制标题
DOI:
10.1038/nbt.2677
复制
发表时间:
2013-11
影响因子:
46.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Ibalizumab is a humanized monoclonal antibody that binds human CD4—a key receptor for HIV—and blocks HIV-1 infection. However, HIV-1 strains with mutations resulting in loss of an N-linked glycan from the V5 loop of the envelope protein gp120 are resistant to ibalizumab. Previous structural analysis suggests that this glycan fills a void between the gp120 V5 loop and the ibalizumab L chain, perhaps causing steric hindrance that disrupts viral entry. If this void contributes to HIV-1 resistance to ibalizumab, we reasoned that ‘refilling’ it by engineering an N-linked glycan into the ibalizumab L chain at a position spatially proximal to gp120 V5 may restore susceptibility to ibalizumab. Indeed, one such ibalizumab variant neutralized 100% of 118 tested diverse HIV-1 strains in vitro, including ten strains resistant to parental ibalizumab. These findings demonstrate that the strategic placement of a glycan in the variable region of a monoclonal antibody can substantially enhance its activity.
登录
查看更多内容
影响因子:
64.8
作者:
Huang J;Ofek G;Laub L;Louder MK;Doria-Rose NA;Longo NS;Imamichi H;Bailer RT;Chakrabarti B;Sharma SK;Alam SM;Wang T;Yang Y;Zhang B;Migueles SA;Wyatt R;Haynes BF;Kwong PD;Mascola JR;Connors M
通讯作者:
Connors M
影响因子:
56.9
作者:
Haynes, BF;Fleming, J;Alam, SM
通讯作者:
Alam, SM
影响因子:
64.8
作者:
Balazs, Alejandro B.;Chen, Joyce;Hong, Christin M.;Rao, Dinesh S.;Yang, Lili;Baltimore, David
通讯作者:
Baltimore, David
DOI:
10.1126/science.1213782
发表时间:
2011-12-02
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Diskin R;Scheid JF;Marcovecchio PM;West AP Jr;Klein F;Gao H;Gnanapragasam PN;Abadir A;Seaman MS;Nussenzweig MC;Bjorkman PJ
通讯作者:
Bjorkman PJ
影响因子:
158.5
作者:
Thigpen, Michael C.;Kebaabetswe, Poloko M.;Brooks, John T.
通讯作者:
Brooks, John T.